API
< Back to situation

[REVISION HISTORY]

Transplantation medicine developments in Bosnia and Herz

6 recorded revisions of this situation.

What changed

2026-10-14 19:46 UTC → 2026-11-13 21:15 UTC · added removed

Bosnia and Herzegovina is working to advance its transplantation medicine through international cooperation and domestic clinical developments. To address the fact that the country is not a member of Eurotransplant, the Health Insurance Fund of Republika Srpska has expanded its medical cooperation with Belarus, facilitating kidney and Belarus to include liver transplants, in addition to kidney transplants. Since 2021, more than 90 kidney transplants have been performed for insured persons from Republika Srpska, costing the Fund 6.1 million KM. The agreement with Belarusian institutions was recently extended to include a facility in Brest. Efforts to join Eurotransplant continue following a letter of intent submitted in January 2024, with a draft agreement under review by though entity-level ministries and hospital administrations. Recent discussions at a national conference held at the Parliamentary Assembly emphasized that while processes to cooperate with Eurotransplant of health have been initiated, these efforts must now translate into tangible results. Experts are utilizing EU TAIEX activities to analyze and improve the country’s legislative and organizational frameworks. cited as primary causes for delays. Clinical advancements have been reported continue, such as at the University Clinical Center Tuzla, where teams have performed complex autologous hematopoietic stem cell transplants. transplants, including a recent procedure for a multiple myeloma patient using a fresh, non-cryopreserved graft. In Mostar, the University Clinical Hospital has moved toward making is working to transition kidney transplantations into a regular clinical practice. At the University Clinical Center of Republika Srpska (UKC RS), officials aim to resume kidney transplantations by the end of 2026, ending a six-year hiatus. This initiative seeks to restart both related-donor and cadaveric transplantations, with long-term goals including bone marrow, liver, and pancreas transplants. Officials noted that the center possesses the capacity to monitor patients in the post-transplantation phase. However, the country continues to face faces a critical shortage. In the Federation of Bosnia and Herzegovina, only 16 transplants have been performed so far in 2026. Waiting lists include 151 patients for kidney transplants, 30 for liver transplants, Experts note that transplant numbers stagnated following the COVID-19 pandemic and 20 for heart transplants. Due to a shortage highlighted the absence of deceased donors, more than half a unified state-level waiting list, as there is no centralized system across the various ministries of successful transplants currently rely on living donors. health.

Versions

  1. 2026-11-13 21:15 UTC Transplantation medicine developments in Bosnia and Herz
  2. 2026-10-14 19:46 UTC Transplantation medicine developments in Bosnia and Herz
  3. 2026-10-13 13:39 UTC Transplantation medicine developments in Bosnia and Herz
  4. 2026-10-10 08:54 UTC Transplantation medicine developments in Bosnia and Herz
  5. 2026-10-10 06:57 UTC Transplantation medicine developments in Bosnia and Herz
  6. 2026-10-09 17:06 UTC Transplantation medicine developments in Bosnia and Herz
  7. 2026-09-25 08:54 UTC Transplantation medicine developments in Bosnia and Herz

Select a version to see what changed compared to the one before it.